RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com
  

Nps Pharmaceuticals Inc patents

Recent patent applications related to Nps Pharmaceuticals Inc. Nps Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Nps Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Nps Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "N" | Nps Pharmaceuticals Inc-related inventors




Date Nps Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
02/02/17Treatment of short bowel syndrome patients with colon-in-continuity
02/02/17Treatment of short bowel syndrome patients with colon-in-continuity
02/02/17Treatment of short bowel syndrome patients with colon-in-continuity
02/02/17Treatment of short bowel syndrome patients with colon-in-continuity
02/02/17Treatment of short bowel syndrome patients with colon-in-continuity
02/02/17Treatment of short bowel syndrome patients with colon-in-continuity
02/02/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
01/26/17Treatment of short bowel syndrome patients with colon-in-continuity
10/15/15Treatment of short bowel syndrome patients with colon-in-continuity
08/27/15Method for treating bone loss using parathyroid hormone
06/04/15Assay system for glp-2 receptor ligands
09/11/14Methods useful in the treatment of bone resorption diseases
09/04/14Cloned glucagon-like peptide-2 receptors
01/23/14Ex vivo determining potential glp-2 receptor modulators
01/16/14Use of d-serine derivatives for the treatment of anxiety disorders
08/08/13Glucagon-like peptide-2 analogs
07/25/13Calcium receptor-active molecules
06/20/13Methods for treatment or prophylaxis of kidney or liver dysfunction
03/21/13Methods for treatment or prophylaxis of kidney or liver dysfunction
11/29/12Azaindoles having serotonin receptor affinity
11/22/12Ex vivo determining potential glp-2 receptor modulators
06/14/12Methods useful in the treatment of bone resorption diseases
01/05/12Ex vivo determining potential glp-2 receptor modulations
07/14/11Treatment of short bowel syndrome patients with colon-in-continuity
06/02/11Method for enzymatic production of glp-2(1-33) and glp-2(1-34) peptides
04/21/11Production of glucagon like peptide 2 and analogs
03/24/11Methods useful in the treatment of bone resorption diseases
01/13/11Glucagon-like peptide-2 analogs
03/18/10Cloned glucagon-like peptide-2 receptors
01/07/10Assay system for glp-2 receptor ligands
11/05/09Isoindolone compounds and their use as metabotropic glutamate receptor potentiators







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Nps Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Nps Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';